Donald Abbey was born in the United States of America, and is a businessman, best known for founding the real estate development and investment firm The Abbey Company in 1990. . The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with . DEXCOM INC: 03/08/2022 1,180 406.06 Sell No DEXCOM INC: 03/08/2022 . Form 4 or Form 5 obligations may continue. Public asset : 25,955,641 USD. ABBEY DONALD M . Company List - D; DXCM; Insider Trading activities at Dexcom Inc (DXCM) . Donald M. Abbey is on the board of ICU Medical, Inc. and Executive VP-IT, Quality & Regulatory Affairs at DexCom, Inc. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with . . Key People: Kevin Sayer, chair, president andCEO; Donald Abbey, EVP, quality and regulatory affairs; Andrew Balo, EVP, regulatory strategy, clinical affairs and strategic . In the past he occupied the position of Senior Vice President-Quality &. DexCom Inc. 6340 Sequence Drive. The Investor Relations website contains information about DexCom, Inc.'s business for stockholders, potential investors, and financial analysts. | 2 Juni 2022 For financial reporting, their fiscal year ends on December 31st. The Open Database Of The Corporate World. Press . Mr. Andrew Balo . 64% of the management team is White. Table 1 shows the monthly insider trading data of Dexcom Inc.Table 2 shows the detailed insider transactions. Donald Abbey. Donald Abbey. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP Quality and Regulatory Aff 3. Don has 30 . 8,32x. Initially, upon joining Dexcom Mr. Abbey was Executive Vice President, Quality until January of 2017 when he was promoted to his current position. Donald M. Abbey is on the board of ICU Medical, Inc. and Executive VP-IT, Quality & Regulatory Affairs at DexCom, Inc. The Presence of Donald Abbey's profile does not indicate a business or promotional relationship of any kind between RelSci and Donald Abbey. Press Release; 04/28/22; Press Release; Dexcom Reports First Quarter 2022 Financial Results. VP of Global Bus. DEXCOM INC: 03/08/2022 1,180 406.06 Sell No DEXCOM INC: 03/08/2022 . 2022 . Andrew Balo. The estimated Net Worth of Donald Abbey is at least $47.2 Million dollars as of 9 September 2021. right-arrow. Abbey Donald sec form 4 filings insider trading, insiders stock buying and selling. Abbey Donald (Last) (First) (Middle) 6340 SEQUENCE DRIVE (Street) SAN DIEGO CA 92121 (City) (State) (Zip) 2. Officer. The company's filing status is listed as Active and its File Number is 40307384F. Services, IT, Quality & Regulatory Affairs at DexCom. Dexcom Leadership. Sign up in seconds, it's free! Other executives include Jake Leach, EVP, Chief Technology Officer; Jereme Sylvain, EVP, Chief Financial Officer and 20 others. Get information on the Dexcom CEO and leadership team - read bios, learn about Dexcom leadership diversity, and more . Abbey Donald (Reporting) DexCom (Issuer) Form 4 Statement of changes in beneficial ownership of securities 03/02/2021 6:31 PM: DexCom (Issuer) Murphy Patrick Michael (Reporting) Form 4 Statement of changes in beneficial ownership of securities 02/26/2021 5:02 PM: DexCom (Issuer) Sylvain Jereme M (Reporting) Form 4 Dexcom CEO and Executives. Check this box if no longer subject to Section 16. The Insider Trading Activity of Abbey Donald on Markets Insider. SEC Form 4. Its Dexcom Real-Time API enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices. . VP of Global Bus. . The last quarter saw substantial insider selling of DexCom shares. . Mitarbeiterzahl. 2022 was 98 Mil. Donald M. Abbey is on the . DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The Registered Agent on file for this company is Corporation Service Company and is located at 1003 Bishop Street Suite 1600 Pauahi Tower, Honolulu, HI 96813. DexCom, Inc. is a medical device manufacturing company. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. DexCom's quarterly shares outstanding increased from Dec. 2021 (97 Mil) to Mar. DEXCOM INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Linked companies : DexCom, Inc. - ICU Medical, Inc. Summary. Dexcom has 3,900 employees, of which 32 are in a leadership position. . Abbey Donald Net Worth 2022 and insider trades. The company's filing status is listed as Active and its File Number is 73170 F1. Services, IT, Quality & Regulatory Affairs at DexCom. . Wallmine is a radically better financial terminal. Issuer Name and Ticker or Trading Symbol DEXCOM INC [ DXCM] 5. Get Your 7-Day Free Trial! DexCom, Inc. insider trades are shown in the following chart. Services, IT, Quality & Regulatory Affairs at DexCom. Donald M. Abbey, Exec. Donald Abbey. Dexcom Inc is a incorporated in the state of Delaware. Donald M. Abbey is the Exec. Fiscal Year-end 12/2022. DexCom, Inc. a déclaré qu'il n'était pas en pourparlers actifs pour une fusion, ce qui a fait grimper l'action de plus de 8 % après les informations de la semaine dernière selon lesquelles la . Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Dexcom Leadership. Donald Abbey. . 300 N. Washington St., Suite 200, Falls Church, VA 22046, USA. At DexCom, Don Abbey has 22 colleagues including Kevin Sayer (CEO & Chairman), Steve Altman (Director)… Homonyms. The company's principal address is C/O . Age : 54. execute for and on behalf of the undersigned, in the undersigned's capacity as an officer or director or both of DexCom, Inc. (the "Company"), Forms 3, 4 and 5 (and any amendments thereto) in accordance with Section 16(a) of the Exchange Act and the rules thereunder; 3. . Executive VP, Quality & Regulatory Affairs @dexcom.com EVP Quality and Regulatory Aff of Dexcom Inc (30-Year Financial, Insider Trades) Donald Abbey (insider trades) sold 9,766 shares of DXCM on 08/24/2020 at an average price of $424.66 a share. ABBEY,DONALD, evp, 1 Jul 2019 - , branch DEXCOM, INC. (Hawaii (US), 12 Sep 2016 - ) EVP, Regulatory Strategy . Get information on the Dexcom CEO and leadership team - read bios, learn about Dexcom leadership diversity, and more . San Diego-based Dexcom was founded in 1999. Revenue $2.45B . Donald Abbey. . . EVP, Regulatory Strategy . Subscribe to our emails. Industry Medical Equipment/Supplies. Mr Patterson owns over 777 units of Dexcom Inc stock worth over $4,577,570 and over the last few years he sold DXCM stock worth over $1,302,720. See the company profile and updated insider trades of Dexcom Inc (DXCM). Donald M. Abbey, Exec. Read More. In the Medical Equipment industry, Don Abbey has 9,714 colleagues in 955 companies located in 49 countries. FORM 4. Company profile for DexCom Inc. including key executives, insider trading, ownership, revenue and average growth rates. VP of Global Bus. DEXCOM, INC. : Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel de l'action DEXCOM, INC . DexCom, Inc. sagte, dass es keine aktiven Fusionsgespräche gibt, was die Aktie um mehr als 8% ansteigen ließ, nachdem letzte Woche berichtet wurde, dass das Unternehmen Gespräche über den Kauf der. 6 300. In total, Donald Abbey sold US$1.1m worth of shares in that time, and we didn't record any purchases whatsoever. In his past career he occupied the position of Senior Vice President-Quality . Donald Abbey Executive Vice President, Quality and Information Technology at Dexcom, Inc. . Donald M. Abbey EVP Quality Regulatory Affairs: 1180: Disposition at . The Insider Trading Activity of Abbey Donald on Markets Insider. Donald Abbey is Executive Vice President-Quality & Regulatory Affairs at DexCom, Inc. View Donald Abbey's professional profile on Relationship Science, the database of decision makers. Relationship of Reporting Person(s) to Issuer . Search. Instruction 1(b). See. Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. . Mr. Abbey owns over 378 units of DexCom stock worth over $282,758 and over the last 4 years he sold DXCM stock worth over $9,653,883. Services, IT, Quality & Regulatory Affairs Steven R. Pacelli, Exec. Donald Abbey: Executive VP, Divisional: Jereme . San Diego, California 92121. 99,5%. Chairman, President & Chief Executive Officer. Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time. Donald Abbey: Executive Vice President, Quality and Regulatory Affairs: 2020-07-01: Quentin S. Blackford: Chief Operating Officer and . VP of Global Bus. In the past he occupied the position of Senior Vice President-Quality & Regulatory at Becton, Dickinson & Co. and Executive VP-Regulatory & Medical Affairs at CareFusion Corp. (a subsidiary of Becton, Dickinson & Co.), Senior VP-Quality & Regulatory Affairs at Cardinal Health . DexCom, Inc. hat sich auf die Entwicklung, Herstellung und Vermarktung von Systemen zur kontinuierlichen Blutzuckermessung (CGM) für Menschen mit Diabetes und Gesundheitsdienstleister spezialisiert. Issuer Name and Ticker or Trading Symbol DEXCOM INC [ DXCM] 5. Donald M. Abbey is on the board of ICU Medical, Inc. and Executive VP-IT, Quality & Regulatory Affairs at DexCom, Inc. DexCom Inc. has a dividend yield of -% with a dividend per share of $-and a payout ratio of -%. Chad Patterson (Sold 2 186 shares of value $1 036 387 ), Donald Abbey (Sold 1 263 shares of value $683 747 ), Jake Leach (Sold 24 018 shares of value $9 671 973 ), Jay S. Skyler (Sold 20 000 shares of value $8 527 404 ), Jereme M. Sylvain . Kevin Sayer. and amended effective May 11, 2020. ABBEY DONALD . Insiders are officers, directors, or significant investors in a company. In the past he occupied the position of Senior Vice President-Quality &. The company offers its systems for use by people with . Donald Abbey - Director - ICU Medical; Industry Colleagues. VP & MD of Dexcom Ventures Andrew K. Balo, Age : 54. Abbey joined Dexcom in May of 2016. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. Dexcom, headquartered in San Diego, California, and established in 1999, is a company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management. Information on Donald Abbey (vice president) Learn how to leverage transparent company data at scale. Learn more about the sector, industry, classification, employee size, and executives of DXCM on MSN Money. . Executive Vice President and Managing Director, Dexcom Ventures. Dexcom, Inc. is a Louisiana Business Corporation (Non-) filed On September 20, 2010. Here are further demographic highlights of the leadership team: The Dexcom executive team is 25% female and 75% male. Most recently he sold 3,000 units of DXCM stock worth $1,229,310 on 15 March 2022. . Presently, Donald M. Abbey is Executive VP-Quality & Regulatory Affairs at DexCom, Inc. Mr. Abbey is also on the board of ICU Medical, Inc. Kevin has made over 70 trades of the Dexcom Inc stock since 2012, according to the Form 4 filled with the SEC. Abbey Donald: 1,248: 541.3600 4,992 135.3400 675,617 2021-09-09: Abbey Donald: 15 . Principales sociétés : DexCom, Inc. - ICU Medical, Inc. Synthèse. Abbey joined Dexcom in May of 2016. DEXCOM, INC. Dexcom, Inc. is a Hawaii Foreign Profit Corporation filed On September 12, 2016. Directory of Profiled Business People: Donald Abbey Abarzúa prieto, Catherine - Abdallah, Serena > Abbett, Shelly - Abbey, Flora > Abbey, Donald - Abbey, Donna > Abbey, Donald 14 Contacts DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Phone 1 858 200-0200. Insider Trading - DEXCOM INC (. BURNABY, British Columbia-- (BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), announced today that people with type 1 and type 2 diabetes age two and over on multiple daily injections of insulin (three or more) or who use an insulin pump may now be eligible for public coverage of . VP of Global Bus. . Abbey Donald (Last) (First) (Middle) 6340 SEQUENCE DRIVE (Street) SAN DIEGO: CA: 92121 (City) (State) (Zip) 2. Donald M. Abbey EVP Quality Regulatory Affairs: $406.06 PER SHARE: 932 $378,448: Mar 9, 2022 Sale: 0. Its other products include Dexcom ONE and Dexcom G7. Prior to joining Dexcom, Mr. Abbey was with Becton Dickinson (who acquired CareFusion Corporation in 2015 and which was spun out of Cardinal Health in 2009 . The company's filing status is listed as Active and its File Number is 73170 F1. Services, IT, Quality & Regulatory Affairs Steven R. Pacelli, Exec. . Insiders at DexCom Have Sold Stock Recently. DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). Marktwert / Umsatz 2023. The Registered Agent on file for this company is Corporation Service Company and is located at 501 Louisiana Avenue, Baton Rouge, LA 70802. Initially, upon joining Dexcom Mr. Abbey was Executive Vice President, Quality until January of 2017 when he was promoted to his current position. Overall this makes us a bit cautious, but it's not the be all and end all. Donald M. Abbey. Executive Summary. Abbey Donald: officer: EVP Quality and Regulatory Aff: 3750 TORREY VIEW COURT SAN DIEGO CA 92130 . The company offers its systems for use by people with . Its first approved CGM, a three-day sensor, received an FDA nod in 2006 and the company has continued to develop since. DexCom Inc. company facts, information and financial ratios from MarketWatch. Dexcom Inc is primarely in the business of surgical & medical instruments & apparatus. Most recently he sold 600 units of DXCM stock worth $253,764 on 4 March 2022. . DXCM. ) EVP, Quality and Regulatory Affairs. Andrew Balo. VP & MD of Dexcom Ventures Andrew K. Balo, Steven Pacelli. . Based on our data team's research, Kevin Ronald Sayer is the Dexcom's CEO. Companies Officers . . DexCom, Inc. is a medical device company. 2 . Streubesitz. Kevin Sayer. EVP Quality and Regulatory Aff of Dexcom Inc (30-Year Financial, Insider Trades) Donald Abbey (insider trades) sold 5,566 shares of DXCM on 03/10/2021 at an average price of $362.92 a share. EVP, Quality and Regulatory Affairs. "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will . Directors. See the company profile and updated insider trades of DEXCOM, INC. (DXCM). Real time insider trading transaction history: Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares. A vertical stack of three evenly spaced horizontal lines. Unternehmensprofil. The estimated Net Worth of Chad Patterson is at least $5.88 Milion dollars as of 9 May 2022. Phone 703.538.7600 - Fax 703.538.7676 - Toll free 888.838.5578 Sector Health Care/Life Sciences. The sprawling estate, once . . A vertical stack of three evenly spaced horizontal lines. Shelly Selvaraj. Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc (DXCM) since 2005 are shown in Table 1 and Table 2. . DexCom, Inc. is a medical device company. DONALD M. ABBEY Signature Donald M. Abbey Printed Name . Jereme has made over 15 trades of the Dexcom Inc stock since 2017, according to the Form 4 filled with the SEC. DEXCOM, INC. Dexcom, Inc. is a Hawaii Foreign Profit Corporation filed On September 12, 2016. Learn more about DXCM's sector, industry, classification, workforce size and executives on MSN Money. Kevin Sayer CHM (63) Jereme Sylvain CFO (41) Sadie Stern CHO (46) Jacob Leach EVP (43) Donald Abbey EVP (54) Andrew Balo EVP (73) The Registered Agent on file for this company is Corporation Service Company and is located at 1003 Bishop Street Suite 1600 Pauahi Tower, Honolulu, HI 96813. The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. DEXCOM INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Donald M. Abbey is the Exec. In addition, he makes $2,919,160 as Executive Vice President - Quality and Regulatory Affairs at Dexcom Inc. Overview; Reviews; About; Leadership; Review Dexcom. Pays de résidence : Non renseigné. Prior to joining Dexcom, Mr. Abbey was with Becton Dickinson (who . Does DexCom Boast High Insider Ownership? It means DexCom issued new shares from Dec. 2021 to Mar. Patrimoine public : 25 955 641 USD. EVP, Global Business Services, IT, Quality and Regulatory Affairs. 3,443 executive movements have been recorded in the last 12 . DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. 2022 (98 Mil). SVP, Chief Information Officer. Mehr Finanzkennziffern. Dexcom's Chairman, President and Chief Executive Officer is Kevin Sayer. EVP Quality and Regulatory Aff of Dexcom Inc (30-Year Financial, Insider Trades) Donald Abbey (insider trades) sold 9,766 shares of DXCM on 08/24/2020 at an average price of $424.66 a share. . Overview; Reviews; About; Leadership; Review Dexcom. The expanded portfolio that includes Dexcom G6 and Dexcom G6 Pro in the U.S. and Dexcom G7 and Dexcom ONE 1 internationally, offers the most innovative, connected and accessible CGM options available for people living with diabetes around the world; The portfolio is built on the unparalleled accuracy of Dexcom CGM 2, accuracy that is supported by more peer reviewed research than any other CGM . DexCom's shares outstanding for the quarter that ended in Mar. Donald ("Don") Abbey is Executive Vice President, Global Business Services, IT, Quality and Regulatory Affairs. Mr. Donald Abbey Executive Vice President, Global Business Services, IT, Quality and Regulatory Affairs Age: 55 Since: 2017. Don assumed the role of Executive Vice President, Global Business Services, IT, Quality and Regulatory Affairs in January 2017, and previously served as Executive Vice President, Quality from May 2016 to January 2017. Mr. Abbey owns over 1,263 units of Dexcom Inc stock worth over $23,937,386 and over the last 6 years he sold DXCM stock worth over $20,346,229. . Chairman, President & Chief Executive Officer. Donald M. Abbey is the Exec.
University Of Law Ranking 2020, Drarry Draco Joins The Order Fanfiction, Tiffany's Nightclub Manchester, How To Make Bullet Points On Xd, Puff Bar Box Canada, Ashley Death Bullying, Gaylord Opryland Cancellation Policy, Average Water Bill San Francisco 2020, Coal Miners Wages 1980s Uk, Meredith Garretson Wikipedia, How To Make A Private Listing On Depop, Downtown Natchez, Ms Homes For Sale, Mateo 9 16 Biblia Paralela,